3gkw
From Proteopedia
(Difference between revisions)
m (Protected "3gkw" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3gkw.png|left|200px]] | [[Image:3gkw.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3gkw", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3gkw| PDB=3gkw | SCENE= }} | {{STRUCTURE_3gkw| PDB=3gkw | SCENE= }} | ||
===Crystal structure of the Fab fragment of Nimotuzumab. An anti-epidermal growth factor receptor antibody=== | ===Crystal structure of the Fab fragment of Nimotuzumab. An anti-epidermal growth factor receptor antibody=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_19584289}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 19584289 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_19584289}} | {{ABSTRACT_PUBMED_19584289}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
| - | *[[Monoclonal Antibody]] | + | *[[Monoclonal Antibody|Monoclonal Antibody]] |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:019584289</ref><references group="xtra"/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Friemann, R.]] | [[Category: Friemann, R.]] | ||
Revision as of 18:32, 25 July 2012
Contents |
Crystal structure of the Fab fragment of Nimotuzumab. An anti-epidermal growth factor receptor antibody
Template:ABSTRACT PUBMED 19584289
About this Structure
3gkw is a 2 chain structure of Monoclonal Antibody with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Talavera A, Friemann R, Gomez-Puerta S, Martinez-Fleites C, Garrido G, Rabasa A, Lopez-Requena A, Pupo A, Johansen RF, Sanchez O, Krengel U, Moreno E. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation. Cancer Res. 2009 Jul 15;69(14):5851-9. Epub 2009 Jul 7. PMID:19584289 doi:10.1158/0008-5472.CAN-08-4518
